We provide access to our own and other pharmaceutical companies’ products, whether to meet unmet medical needs or for use in clinical trials. This includes providing access to medicines that have received regulatory approval, but may not be available in a specific patient’s own country (‘unlicensed’ medicines).

Ethical unlicensed access helps protect patients from the growing threat of counterfeit medicines distributed online.